Cargando…
Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib
Brain metastases are a common complication of non-small-cell lung cancer (NSCLC). The role of chemotherapy in the treatment of brain metastases has not been clearly defined. Emerging case reports of patients with recurrent NSCLC treated as part of the Expanded Access Programme reveal that gefitinib...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750244/ https://www.ncbi.nlm.nih.gov/pubmed/14661048 http://dx.doi.org/10.1038/sj.bjc.6601478 |